Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | EP0031 |
| Trade Name | |
| Synonyms | EP-0031|EP 0031|A400|A-400|A 400|KL590586|Lunbotinib |
| Drug Descriptions |
EP0031 inhibits RET, potentially leading to decreased growth of tumors expressing RET fusions and mutations, and resulting in antitumor activity (NCI Drug Dictionary, J Clin Oncol 41, 2023 (suppl 16; abstr 3007)). |
| DrugClasses | RET Inhibitor 53 |
| CAS Registry Number | 2479961-46-9 |
| NCIT ID | C189067 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + EP0031 + Pemetrexed Disodium | Carboplatin EP0031 Pemetrexed Disodium | 0 | 1 |
| Cisplatin + EP0031 + Pemetrexed Disodium | Cisplatin EP0031 Pemetrexed Disodium | 0 | 1 |
| EP0031 | EP0031 | 3 | 0 |